Brief

On March 3, 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an update regarding New Chief Executive appointed at MHRA. Lawrence Tallon has been appointed as the new Chief Executive Officer of the MHRA, succeeding Dame June Raine DBE who is retiring after leading the organisation since 2019. Mr. Tallon will begin his role from April 1, 2025, and will focus on accelerating patient access to innovative medicines while maintaining the highest standards of safety and effectiveness.

Hello!

To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.

Go to Home Page

Highlights content goes here...

Hello!

To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.

Go to Home Page

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies